Aflac shares may be trading about 10% above fair value as analysts project declining revenue and thinner profit margins. The stock closed at $129.55, while the most followed narrative pegs fair value at $117.71, implying the stock is overvalued. Analysts expect Aflac's revenue to shrink by 1.1% annually over the next three years, with profit margins contracting from 25.6% to 20.5%. However, a separate discounted cash flow model from Simply Wall St estimates fair value at $168.47, suggesting the stock is undervalued. Aflac's heavy reliance on Japan, declining net earned premiums, higher technology costs, and softer U.S. sales growth could challenge the fair value story.
Aflac IncorporatedAnalysts expect revenue to shrink 1.1% annually and profit margins to contract from 25.6% to 20.5%, implying overvaluation relative to fair value estimate of $117.71.